128 related articles for article (PubMed ID: 37257299)
1. Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer.
Yu J; Wang L; Ling Y; Xiao X; Gong J; Jin H; Xu J; Chen P; Xie X; Zhang L
Colloids Surf B Biointerfaces; 2023 Jul; 227():113381. PubMed ID: 37257299
[TBL] [Abstract][Full Text] [Related]
2. Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis.
Yu J; Xie X; Wang L; Liu W; Xu H; Lu X; Li X; Ren J; Li W
Int J Nanomedicine; 2023; 18():663-677. PubMed ID: 36798532
[TBL] [Abstract][Full Text] [Related]
3. Versatile chondroitin sulfate-based nanoplatform for chemo-photodynamic therapy against triple-negative breast cancer.
Yu J; Xu J; Jiang R; Yuan Q; Ding Y; Ren J; Jiang D; Wang Y; Wang L; Chen P; Zhang L
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130709. PubMed ID: 38462120
[TBL] [Abstract][Full Text] [Related]
4. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment.
Khondee S; Chittasupho C; Tima S; Anuchapreeda S
Curr Drug Deliv; 2018; 15(3):406-416. PubMed ID: 28707580
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
[TBL] [Abstract][Full Text] [Related]
7. MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer.
Cao Z; Liu R; Li Y; Luo X; Hua Z; Wang X; Xue Z; Zhang Z; Lu C; Lu A; Liu Y
Breast Cancer Res; 2023 Jan; 25(1):3. PubMed ID: 36635685
[TBL] [Abstract][Full Text] [Related]
8. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin.
Liu H; Wu S; Yu J; Fan D; Ren J; Zhang L; Zhao J
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():55-63. PubMed ID: 28415498
[TBL] [Abstract][Full Text] [Related]
9. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG
Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790
[TBL] [Abstract][Full Text] [Related]
11. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer.
Dai W; Yang F; Ma L; Fan Y; He B; He Q; Wang X; Zhang H; Zhang Q
Biomaterials; 2014 Jul; 35(20):5347-5358. PubMed ID: 24726747
[TBL] [Abstract][Full Text] [Related]
12. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
[TBL] [Abstract][Full Text] [Related]
13. Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles.
Zou Y; Zhou Y; Jin Y; He C; Deng Y; Han S; Zhou C; Li X; Zhou Y; Liu Y
ACS Appl Mater Interfaces; 2018 Jun; 10(22):18585-18600. PubMed ID: 29749228
[TBL] [Abstract][Full Text] [Related]
14. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
[TBL] [Abstract][Full Text] [Related]
15. Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles.
Zhao Y; Alakhova DY; Zhao X; Band V; Batrakova EV; Kabanov AV
Nanomedicine; 2020 Feb; 24():102124. PubMed ID: 31756533
[TBL] [Abstract][Full Text] [Related]
16. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells.
Lin YJ; Liu YS; Yeh HH; Cheng TL; Wang LF
Int J Nanomedicine; 2012; 7():4169-83. PubMed ID: 22904627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
